Acute toxicity of boron nitride nanotubes in-vitro and in-vivo
Public Domain
-
2016/06/04
Details
-
Personal Author:Barger M ; Erdely A ; Eye T ; Kodali V ; Porter, Dale ; Roach K ; Roberts J ; Schwegler-Berry D ; Smith K ; Wolfarth M
-
Description:Boron nitride nanotubes (BNNTs) are an emerging engineered nanomaterial that has attracted significant attention due to its superior electrical, chemical, and thermal properties. As the number of applications grow, occupational exposures will likely increase. Since its toxicity is largely unknown, we performed acute in-vitro and in-vivo exposure studies with 13-23 nm diameter x 0.6-1.6 microm length BNNTs. THP-1 wild-type and NLRP3 knockout human monocytic cells were exposed to 0-100 microg/ml and male C57BL/6 mice were exposed by pharyngeal aspiration to 4 or 40 microg BNNTs and sacrificed 4 and 24 h post-exposure. The multi-walled carbon nanotube-7 (MWCNT-7) served as a particle control. In-vitro, BNNT induced a dose-dependent increase in cytotoxicity. This was confirmed in vivo by increased bronchoalveolar lavage levels of lactate dehydrogenase, a measure of lung cytotoxicity. In vitro, lysosomal destabilization, likely a result of particle uptake, was evident by acridine orange staining. Subsequent NLRP3 inflammasome activation was demonstrated by a dose dependent increase in IL-1beta protein as well as cathepsin B and caspase 1 activity. Toxicity, and IL-1beta production were attenuated in exposed NLRP3 knockout THP-1 cells. In-vivo, elevated pulmonary IL-1beta confirmed in vitro findings. Consistent with suspected BNNT-induced inflammation, pulmonary neutrophil influx and inflammatory markers (Il6, Ccl2, Ccl22, Cxcl2) increased in a dose-dependent manner. In general, toxicity induced by BNNTs was less in comparison to MWCNT-7. Taken together, these results demonstrate that BNNTs induce inflammation in vitro and in vivo in part due to NLRP3 inflammasome activation and sub-chronic in vivo studies are warranted. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
NIOSHTIC Number:nn:20048175
-
Citation:nanoTOX 2016, Proceedings of the 8th International Nanotoxicology Congress, June 1-4, 2016, Boston, Massachusetts. Boston: MA: International Nanotoxicology Congress, 2016 Jun; :162
-
CAS Registry Number:
-
Federal Fiscal Year:2016
-
NORA Priority Area:
-
Peer Reviewed:False
-
Source Full Name:nanoTOX 2016, Proceedings of the 8th International Nanotoxicology Congress, June 1-4, 2016, Boston, Massachusetts
-
Collection(s):
-
Main Document Checksum:urn:sha-512:c1ef0c2bc58335492a607808221ef3a5cb38f62951e9af473700c1ec69948f7bde3c4df1ddc65e2632374f4b7ed3a96a185fe9724d741d2c00b08ed6e9b7b9f8
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like